企業プロフィール
Kronos Bio 株価・ニュース・カタリスト
- ティッカー:
- KRON
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for KRON.
企業概要
事業概要
Kronos Bio was an oncology company focused on epigenetic and transcriptional regulation in cancer before its restructuring and public-market decline. Its story centered on chromatin biology and targeted cancer therapy.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ before restructuring, Kronos sat in oncology biotechnology.
ビジネスモデルの特徴
The business depended on clinical data, target validation, and the ability to convert epigenetic science into therapeutic value.
バイオ業界での位置付け
Kronos belongs to the historical oncology-biotech set rather than the current live public-company universe.
今後のカタリスト
- Kronos is now mostly a legacy / closeout story, so the catalysts are transaction or asset-resolution updates rather than fresh pipeline milestones. The market no longer treats it like an active growth name.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。